FINHUB Insights

TECH · Q3 FY25 · Jan 1 – Mar 31, 2025

Bio-Techne Q3 FY25: where the revenue came from and where it went

Bio-Techne Q3 FY25: revenue $0.32B (+4% year over year). Net profit $0.02B. Largest cohort Consumables $0.26B. The whole income statement as a sankey diagram from the SEC filing.

Period
Jan 1 – Mar 31, 2025
Reported
May 8, 2025 10-Q
Sankey diagram of Bio-Techne's income statement for Q3 FY25: revenue of $0.32 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$0.32B +4% year over year
Gross profit$0.22B 68% margin
Operating profit$0.04B 12% margin
Net profit$0.02B 7% margin

The numbers

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Mar 31, 2025).
ItemValueShare of revenueYear over year
Revenue 0.32 100% +4%
Consumables 0.26 82% +4%
Services 0.03 9% +7%
Instruments 0.03 8% −1%
Royalty 0.01 2% +7%
Cost of revenue−0.1032%
Gross profit0.2268% margin+0pp
SG&A−0.1548%+11pp
Other−0.038%+0pp
Operating profit0.0412% margin−10pp
Tax−0.02
Net profit0.027%−9pp
Filing on EDGAR More quarters of TECH

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.